⚠️ Cataract Surgery in Patients with Wet AMD: Proceed With Caution
Please hit the ❤️ at the top or bottom of this email to help others discover All About Vision With Dr. Kondrot. Your subscription directly supports my ongoing humanitarian work—delivering free eye surgeries and care where it's needed most.
🟠 STORY AT A GLANCE
Patients with wet age-related macular degeneration (AMD) are at elevated risk of macular edema after cataract surgery.
Surgical trauma can trigger inflammatory or vascular responses that worsen macular fluid accumulation.
For patients with active or recent wet AMD, cataract surgery may destabilize the macula and lead to vision loss.
Administering an intravitreal anti-VEGF injection prior to surgery may reduce the risk of post-operative macular edema and preserve visual outcomes.
Coordinated care between cataract and retina specialists is essential for optimizing safety and results.
⚠️ Cataract Surgery in Patients with Wet AMD: Proceed With Caution
Cataract surgery can dramatically improve visual clarity—but in patients with wet AMD, it also carries risk. While removing the cloudy lens might seem like the obvious next step, there’s more happening beneath the surface.
The macula, already fragile in wet AMD, can become destabilized by the inflammation and fluid shifts caused by surgery. The result? Post-operative macular edema—swelling in the central retina that can severely blur or distort vision.
Even patients who appear stable can experience recurrence of choroidal neovascular activity or worsening fluid post-op. That’s why retinal specialists and cataract surgeons must align on strategy—especially regarding timing and pre-treatment.
👁️ Why Is Macular Edema a Risk After Cataract Surgery?
Cataract surgery involves ultrasonic energy (phacoemulsification), intraocular fluid dynamics, and postoperative inflammation—all of which can:
Disrupt the blood-retinal barrier
Trigger cytokine and VEGF release
Increase vascular permeability
Lead to accumulation of fluid in or under the macula
This is a bigger issue in patients with wet AMD, where fragile abnormal blood vessels already exist beneath the retina.
💉 The Role of Anti-VEGF Injections Pre-Surgery
Anti-VEGF (vascular endothelial growth factor) agents such as ranibizumab (Lucentis), aflibercept (Eylea), or bevacizumab (Avastin) work by:
Stabilizing abnormal blood vessels
Reducing vascular permeability
Preventing leakage that contributes to macular edema
Administering an anti-VEGF injection within 1–4 weeks prior to cataract surgery has been shown to reduce the likelihood of post-op edema in high-risk patients.
In some cases, a second injection may be given at the time of surgery or shortly after, depending on disease activity and OCT findings.